Rock Springs Capital Management LP Nuvation Bio Inc. Transaction History

Rock Springs Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.75 - $10.05 $1.83 Million - $2.38 Million	-236,609 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$7.78 - $10.0 $37,935 - $48,760	-4,876 Reduced 2.02%	236,609 $2.35 Million
Q2 2021 Aug 16, 2021	SELL	$9.22 - $14.48 $1.48 Million - $2.33 Million	-160,603 Reduced 39.94%	241,485 $2.25 Million
Q1 2021 May 17, 2021	BUY	$9.0 - $14.57 $3.62 Million - $5.86 Million	402,088 New	402,088 $4.2 Million

159

157M

3.2K

98.7K

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $608M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.